48 reports of this reaction
1.7% of all CHLORZOXAZONE reports
#11 most reported adverse reaction
DYSPNOEA is the #11 most commonly reported adverse reaction for CHLORZOXAZONE, manufactured by Actavis Pharma, Inc.. There are 48 FDA adverse event reports linking CHLORZOXAZONE to DYSPNOEA. This represents approximately 1.7% of all 2,802 adverse event reports for this drug.
Patients taking CHLORZOXAZONE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for CHLORZOXAZONE, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for CHLORZOXAZONE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 48 FDA reports for CHLORZOXAZONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 1.7% of all adverse event reports for CHLORZOXAZONE, making it a notable side effect.
If you experience dyspnoea while taking CHLORZOXAZONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.